Baird analyst Brian Skorney raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $112.00 (from $96.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE